8 clinical signs associated with impending death in patients with cancer identified
the ONA take:
According to a new study published in the journal Cancer, researchers at The University of Texas MD Anderson Cancer Center in Houston, Texas, have identified eight highly specific cognitive and physical signs associated with impending death in patients with cancer.
For the prospective study, researchers identified 357 patients with cancer admitted to palliative care units at MD Anderson Cancer Center and Barretos Cancer Hospital in Brazil. Of those patients, 57% died.
The team observed 52 cognitive and physical signs twice daily from the time of admission to discharge or death. Of those, researchers were able to identify eight signs that were most highly associated with impending death within 3 days of presentation.
Those signs include: decreased response to verbal stimuli, inability to close eyelids, nonreactive pupils, decreased response to visual stimuli, neck hyperextension, upper gastrointestinal bleeding, drooping of the nasolabial fold, and grunting of vocal cords.
The researchers note that although this information will not alter clinical practice, it may be helpful knowing that death is imminent so that caregivers can plan appropriately.
The authors also stress that these findings should only be applied to patients with cancer and not to other causes of death.
Researchers identified eight highly specific cognitive and physical signs associated with impending death in patients with cancer.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
- Radiotherapy is Essential in Treating Brain Tumors But Associated With Significant Adverse Events
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|